Biomarker Testing in Lung Cancer

Insight regarding the role of comprehensive biomarker testing non-small cell lung cancer to help individualize therapy.

EP. 1: Importance of Biomarker Testing in Non-Small Cell Lung Cancer

May 10th 2021

Bonnie Addario, a lung cancer survivor, explains the importance of comprehensive biomarker testing in patients with lung cancer to treat to target and coverage from insurance companies.

EP. 2: Treatment Targets in Non-Small Cell Lung Cancer

September 23rd 2021

Treating patients with lung cancer by identifying specific biomarkers to use the correct combination therapy and what it means for a biomarker to be actionable.

EP. 3: Advocacy and Education for Biomarker Testing in Non-Small Cell Lung Cancer

September 23rd 2021

Ms. Addario shares the promising hope for patients with lung cancer and describes the steps in the process of biomarker testing for patients with lung cancer.

EP. 4: Resources and Tools for Non-Small Cell Lung Cancer

September 23rd 2021

Ms. Addario, lung cancer survivor, encourages patients with non-small cell lung cancer to use all the resources and tools that are available to them.

EP. 5: Receiving a Diagnosis of Non-Small Cell Lung Cancer

September 30th 2021

Allison Collins describes her diagnosis with KRAS-positive non-small cell lung cancer and the symptoms that led her to seek medical attention.

EP. 6: Navigating Emotional Response to a Lung Cancer Diagnosis

September 30th 2021

Considerations for the emotional impact of a lung cancer diagnosis and how patients can be supported during their treatment journey.

EP. 7: NSCLC: Understanding Staging and Diagnostic Testing

September 30th 2021

Dr. Vamsidhar Velcheti provides an expert’s insight on the testing and staging that must be performed during a diagnosis of non-small cell lung cancer.

EP. 8: Undergoing Genetic Testing for Non-Small Cell Lung Cancer

October 7th 2021

Allison Collins reflects on the genetic testing she underwent after receiving a non-small cell lung cancer diagnosis and describes the treatment options presented to her at that time.

EP. 9: NSCLC: What Are Biomarkers and How Do They Affect Treatment?

October 7th 2021

An in-depth explanation of biomarkers in non-small cell lung cancer, particularly how they can affect the disease and treatment options.

EP. 10: The Importance of Clinical Trials in Non-Small Cell Lung Cancer

October 7th 2021

A brief discussion on the importance of enrolling in clinical trials and when that may be an option in non-small cell lung cancer.

EP. 11: Non-Small Cell Lung Cancer: Taking a Break From Treatment

October 14th 2021

Allison Collins shares her experience undergoing a break from therapy after she responded well to treatment for non-small cell lung cancer.

EP. 12: NSCLC: Future Directions in Care and Take-Home Messages

October 14th 2021

Shared insight on novel treatments for non-small cell lung cancer and how patients should advocate for themselves and seek best available care.

EP. 13: Biomarker Testing in Non-Small Cell Lung Cancer

October 14th 2021

Stephen Liu, MD, and Danielle Hicks describe the purpose and the importance of biomarker testing in non-small cell lung cancer.

EP. 14: Discussing Biomarker Testing in NSCLC With Patients

October 21st 2021

Key opinion leaders explain how to discuss biomarker testing with non-small cell lung cancer patients, as well as the common questions they field.

EP. 15: Biomarker Testing and the Impact on Treatment Selection for NSCLC

October 21st 2021

Stephen Liu, MD, and Danielle Hicks illustrate how molecular testing impacts targeted therapy selection in non-small cell lung cancer.

EP. 16: Targeted Therapies in Non-Small Cell Lung Cancer

October 28th 2021

Thought leaders give an overview on KRAS-mutated non-small cell lung cancer and the treatment options available.

EP. 17: The Importance of Shared Decision-Making in Receiving Molecular Testing for NSCLC

October 28th 2021

Stephen Liu, MD, and Danielle Hicks clarify the importance of involving patients and caregivers in discussions about non-small cell lung cancer molecular testing.